Phase II trial of etoposide in advanced prostate cancer.
D000368:Aged; D001855:Bone Marrow Diseases / Q000139:chemically induced; D004341:Drug Evaluation; D005047:Etoposide / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D005047:Etoposide; D011034:Podophyllotoxin